======= B3GALT6 =======
== Gene Information ==
* **Official Symbol**: B3GALT6
* **Official Name**: beta-1,3-galactosyltransferase 6
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=126792|126792]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96L58|Q96L58]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=B3GALT6&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20B3GALT6|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/615291|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The enzyme encoded by this intronless gene is a beta-1,3-galactosyltransferase found in the medial Golgi apparatus, where it catalyzes the transfer of galactose from UDP-galactose to substrates containing a terminal beta-linked galactose moiety. The encoded enzyme has a particular affinity for galactose-beta-1,4-xylose found in the linker region of glycosamines. This enzyme is required for glycosaminoglycan synthesis. [provided by RefSeq, Jun 2013].
* **UniProt Summary**: Beta-1,3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-linked galactose residue. Has a preference for galactose-beta-1,4-xylose that is found in the linker region of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. Has no activity towards substrates with terminal glucosamine or galactosamine residues. {ECO:0000269|PubMed:11551958}.
|Galactosyl T|
|galactosylxylosylprotein 3-beta-galactosyltransferase activity|
|UDP-galactosyltransferase activity|
|UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity|
|Golgi medial cisterna|
|galactosyltransferase activity|
|chondroitin sulfate biosynthetic process|
|heparan sulfate proteoglycan biosynthetic process|
|chondroitin sulfate proteoglycan biosynthetic process|
|heparan sulfate proteoglycan metabolic process|
|chondroitin sulfate metabolic process|
|chondroitin sulfate proteoglycan metabolic process|
|proteoglycan biosynthetic process|
|Golgi cisterna membrane|
|proteoglycan metabolic process|
|glycosaminoglycan biosynthetic process|
|mucopolysaccharide metabolic process|
|aminoglycan biosynthetic process|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|sulfur compound biosynthetic process|
|protein glycosylation|
|macromolecule glycosylation|
|glycosylation|
|glycoprotein biosynthetic process|
|sulfur compound metabolic process|
|glycoprotein metabolic process|
|carbohydrate derivative biosynthetic process|
|Golgi membrane|
|Golgi apparatus|
|oxoacid metabolic process|
|endoplasmic reticulum|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|organonitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|small molecule metabolic process|
|macromolecule biosynthetic process|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|1.82|
|[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|2.07|
|[[:results:exp240|Pyridostatin 4μM R05 exp240]]|3.08|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4779
* **Expression level (log2 read counts)**: 4.73
{{:chemogenomics:nalm6 dist.png?nolink |}}